View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

WORLDLINE : EGM - Availability of preparatory documents

WORLDLINE : EGM - Availability of preparatory documents Extraordinary General Meeting of January 8, 2026Availability of preparatory documents Paris La Défense, December 18, 2025 – The shareholders of Worldline [Euronext: WLN] are convened to an Extraordinary General Meeting on Thursday, January 8, 2026 at 10:00 a.m. (Paris time) at Cloud Business Center – 10 bis rue du Quatre Septembre – 75002 Paris. The meeting notice (avis préalable de réunion) including the agenda, the draft resolutions and the terms and conditions of participation and voting at the General Meeting, was published in th...

 PRESS RELEASE

WORLDLINE : AGE - Modalités de mise à disposition des documents prépar...

WORLDLINE : AGE - Modalités de mise à disposition des documents préparatoires Assemblée Générale Extraordinaire du 8 janvier 2026Modalités de mise à disposition des documents préparatoires Paris La Défense, le 18 décembre 2025 – Les actionnaires de Worldline [Euronext: WLN] sont convoqués en Assemblée Générale Extraordinaire le jeudi 8 janvier 2026 à 10 heures au Cloud Business Center – 10 bis rue du Quatre Septembre – 75002 Paris L’avis préalable de réunion comportant l’ordre du jour, les projets de résolutions et les modalités de participation et de vote à l’Assemblée Générale ont été ...

Carole Braudeau
  • Carole Braudeau

Credit Morning 12/18/2025

Moody’s downgrades SES rating from Baa3/negative to Ba1/stable|ams OSRAM launches a € 300m tender offer on the 2027 convertible bonds|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 18/12/2025

Moody’s dégrade le rating de SES de Baa3/négative à Ba1/stable|ams OSRAM lance une offre d’achat de 300 m EUR sur les obligations convertibles 2027|

 PRESS RELEASE

EssilorLuxottica and Burberry announce licensing partnership renewal

EssilorLuxottica and Burberry announce licensing partnership renewal EssilorLuxottica and Burberryannounce licensing partnership renewal Paris, France and London, United Kingdom (18 December 2025) – EssilorLuxottica and Burberry today announced the renewal of their licensing agreement for the development, production and global distribution of eyewear under the Burberry brand. The existing agreement, expiring on December 31, 2025, has been extended through December 31, 2035. Building on a shared legacy of creativity, craftsmanship and innovation, the renewal reinforces a long-standing pa...

 PRESS RELEASE

EssilorLuxottica et Burberry renouvellent leur accord de licence

EssilorLuxottica et Burberry renouvellent leur accord de licence EssilorLuxottica et Burberryrenouvellent leur accord de licence Paris, France et Londres, Royaume-Uni (18 décembre 2025) – EssilorLuxottica et Burberry ont annoncé aujourd’hui le renouvellement de leur accord de licence pour la conception, la production et la distribution mondiale de lunettes sous la marque Burberry. L’accord en vigueur, venant à échéance le 31 décembre 2025, a été prolongé jusqu’au 31 décembre 2035. S'appuyant sur une culture partagée de créativité, de savoir-faire et d'innovation, ce renouvellement vient...

 PRESS RELEASE

EssilorLuxottica e Burberry rinnovano l’accordo di licenza

EssilorLuxottica e Burberry rinnovano l’accordo di licenza EssilorLuxottica e Burberry rinnovano l’accordo di licenza Parigi, Francia e Londra, Regno Unito (18 dicembre 2025) – EssilorLuxottica e Burberry annunciano il rinnovo dell’accordo di licenza per lo sviluppo, la produzione e la distribuzione a livello globale di occhiali a marchio Burberry. L’accordo in essere, con scadenza prevista il 31 dicembre 2025, viene rinnovato fino al 31 dicembre 2035. Con una tradizione condivisa di creatività, artigianalità e innovazione, il rinnovo rafforza una collaborazione avviata tra le due socie...

Getlink SE: 2 directors

Two Directors at Getlink SE bought 8,584 shares at between 15.154EUR and 15.180EUR. The significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

EssilorLuxottica to acquire Signifeye, further growing its ophthalmolo...

EssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprint EssilorLuxottica to acquire Signifeye,further growing its ophthalmology clinics footprint Paris, France (12 December 2025) – EssilorLuxottica announced today the acquisition of Signifeye, a leading Belgian ophthalmology platform delivering top-tier patient care across 15 eye centers and clinics in the Flanders region. The transaction comes soon after the recent acquisition of Optegra, a fast-growing and highly integrated ophthalmology platform in Europe operating over 70 clinics in the UK, Czech Re...

 PRESS RELEASE

EssilorLuxottica va acquérir Signifeye, poursuivant l’extension de son...

EssilorLuxottica va acquérir Signifeye, poursuivant l’extension de son réseau de cliniques ophtalmologiques EssilorLuxottica va acquérir Signifeye,poursuivant l’extension de son réseau de cliniques ophtalmologiques Paris, France (12 décembre 2025) – EssilorLuxottica a annoncé aujourd’hui l’acquisition de Signifeye, une plateforme d’ophtalmologie belge de premier plan qui propose aux patients des prestations médicales de haut niveau grâce à 15 cliniques et centres de l’œil situés en Flandre. Cette transaction fait suite à la récente acquisition d’Optegra, une plateforme européenne d'ophta...

 PRESS RELEASE

EssilorLuxottica acquisisce Signifeye e continua ad espandere la sua r...

EssilorLuxottica acquisisce Signifeye e continua ad espandere la sua rete di cliniche oftalmiche EssilorLuxottica acquisisce Signifeyee continua ad espandere la sua rete di cliniche oftalmiche Parigi, Francia (12 dicembre 2025) – EssilorLuxottica annuncia l’acquisizione di Signifeye, una delle principali piattaforme oftalmiche belghe che offre percorsi di cura di eccellenza attraverso 15 cliniche oftalmiche e centri diagnostici nella regione delle Fiandre. L’operazione fa seguito alla recente acquisizione di Optegra, una piattaforma oftalmica europea in forte espansione e perfettamente...

 PRESS RELEASE

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate t...

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate the future of smart eyewear EssilorLuxottica joins forces with Fondazione Chips-ITto accelerate the future of smart eyewear Paris, France (10 December 2025) – EssilorLuxottica announces it is joining forces with Fondazione Chips-IT, Italy’s research center specializing in advanced integrated-circuit design, during today’s presentation of the foundation’s 2026-2028 strategic plan. This collaboration aims to further strengthen the Group’s leadership in smart eyewear by advancing application-specific chip development within...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch